Genomic polymorphism within interleukin-1 family cytokines influences the outcome of septic patients

Critical Care Medicine

Volumn 30, Issue 5, 2002, Pages 1046-1050

  Ma, Penglin ^a   Chen, Dechang ^a   Pan, Jiaqi ^a   Du, Bin ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Alleles; Cytokines; Gene polymorphism; Genotype; Interleukin 1 receptor antagonist; Interleukin 1 ; Interleukin 1 ; Outcome; Sepsis; Susceptibility

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RESTRICTION ENDONUCLEASE;

ADULT; AGED; ALLELISM; ARTICLE; BASE PAIRING; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HIGH RISK POPULATION; HUMAN; INTENSIVE CARE; INTRON; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SEPSIS; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 0036250135     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200205000-00015     Document Type: Article

References (21)

1. The pathogenesis of sepsis
2. Biologic basis for interleukin-1 in disease
3. Interleukin-1 receptor antagonist: Role in biology
4. Proinflammatory cytokine genomic polymorphism and critical illness
5. IL1B gene polymorphisms influence the course and severity of inflammatory bowel disease
6. IL-1 receptor antagonist (IL-1RA) gene polymorphism in Sjogren's syndrome and rheumatoid arthritis
7. Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus
8. Comparison of two polymorphisms of the interleukin-1 gene family: Interleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis
9. A simple salting out procedure for extracting DNA from human nucleated cells
10. Polymorphic tandem repeat region in interleukin-1 alpha intron 6
11. Anti-inflammatory therapies to treat sepsis and septic shock: A reassessment
12. A genomic polymorphism within the tumor necrosis factor locus influences plasma TNFα concentrations and outcome of patients with severe sepsis
13. Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune diseases
14. Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: A phase III, randomized, double-blind, placebo-controlled, multicenter trial
15. Current topics. Sepsis
16. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro
17. Genomic polymorphism of interleukin-1ra and tumor necrosis factor define an extended haplotype for risk assessment in severe sepsis
18. Presence of the IL-1RA allele 2 (ILRN*2) is associated with enhanced IL-lbeta production in vitro
19. IL-1 receptor antagonist (IL-1ra) plasma levels are coordinately regulated by both IL-1ra and IL-1beta genes
20. Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1beta on tuberculosis
21. Cytokine production by normal human monocytes: Inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1ra) gene polymorphism